Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAPAS-3 pediatric HIV antiretroviral regimen study
PACTR201006000222401Completed
- Sponsor
- Medical Research Council
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Randomised, open-label trial of stavudine, lamivudine, nevirapine, efavirenz, abacavir and 1 more in human immunodeficiency virus infection (HIV), sponsored by Medical Research Council. Started Jul 2010; status: completed.
02
Drugs
stavudinelamivudinenevirapineefavirenzabacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201006000222401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201006000222401.